Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 94, Issue 1, Pages 37-51
Publisher
Springer Nature
Online
2013-02-27
DOI
10.1038/clpt.2012.221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions
- (2012) Gian Camenisch et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Transporter-Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
- (2012) K Yoshida et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues
- (2011) Chengjie Ji et al. ANALYTICA CHIMICA ACTA
- Comparison of the Pharmacokinetics of Pitavastatin by Formulation and Ethnic Group
- (2011) Steve Warrington et al. CLINICAL DRUG INVESTIGATION
- Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study
- (2011) K Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers
- (2011) Akihiro Yamada et al. Pharmacogenetics and Genomics
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction
- (2010) Kristian M. Bailey et al. Circulation-Cardiovascular Genetics
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
- (2010) Takao Watanabe et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Impact of OATP transporters on pharmacokinetics
- (2009) A Kalliokoski et al. BRITISH JOURNAL OF PHARMACOLOGY
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
- (2009) T. Watanabe et al. DRUG METABOLISM AND DISPOSITION
- OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers
- (2009) J. Wen et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
- (2009) Agnès Poirier et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and Fexofenadine
- (2009) Agnès Poirier et al. MOLECULAR PHARMACEUTICS
- The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
- (2009) Sarah Shugarts et al. PHARMACEUTICAL RESEARCH
- Effects of theCYP2C9*13allele on the pharmacokinetics of losartan in healthy male subjects
- (2009) Z. Li et al. XENOBIOTICA
- Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
- (2008) S. Kitamura et al. DRUG METABOLISM AND DISPOSITION
- Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
- (2008) Kazuya Maeda et al. Drug Metabolism and Pharmacokinetics
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- (2008) Suttasinee Suwannakul et al. JOURNAL OF HUMAN GENETICS
- Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
- (2008) T. Watanabe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now